美国精神病学杂志的一项研究显示,高剂量的安非他林治疗ADHD会增加精神病/痴迷的风险五倍以上. Study in American Journal of Psychiatry reveals high amphetamine doses for ADHD increase psychosis/mania risk by over five times.

《美国精神病学杂志》刊登的McLean医院的一项研究表明,对ADDHD(包括Adderall和Vyvanse)规定的高剂量苯丙胺,使精神错乱或狂躁的风险大幅提高五倍以上。 A study from McLean Hospital, published in the American Journal of Psychiatry, indicates that high doses of amphetamines prescribed for ADHD, including Adderall and Vyvanse, significantly elevate the risk of psychosis or mania by over five times. 研究人员分析了2005年至2019年的病人记录,发现最近苯丙胺使用者的风险增加了63%,而重剂量将这一风险提高到81%。 Analyzing patient records from 2005 to 2019, researchers found that recent amphetamine users had a 63% increased risk, with heavy doses raising that risk to 81%. 调查结果强调,在开药时必须考虑到剂量因素。 The findings underscore the importance of dosage considerations when prescribing these medications.